About Breast Lymphoma
Key Highlights
-
Managed by a specialized Hemato Oncologist with expertise in lymphatic cancers.Treatment is systemic, targeting lymphoma cells throughout the body, not just the breast.Utilizes advanced, personalized protocols including chemotherapy, immunotherapy, and sometimes radiation.High remission rates are achievable for many subtypes with modern treatment regimens.Multidisciplinary approach ensures comprehensive care addressing both the cancer and patient well-being.
Who is this surgery for?
- Presence of a painless, rapidly growing lump or mass in the breast, often without typical breast cancer characteristics on imaging.
- Confirmed diagnosis of Non-Hodgkin Lymphoma (e.g., Diffuse Large B-Cell Lymphoma) from a breast tissue biopsy.
- Swollen lymph nodes in the armpit (axilla) or other areas alongside a breast mass.
- Systemic symptoms such as unexplained fever, night sweats, or significant weight loss (B symptoms).li>
- Involvement of both breasts (bilateral disease), which is more common in primary breast lymphoma than in carcinoma.
How to prepare
- Comprehensive diagnostic workup: Core needle or excisional biopsy for definitive histopathology and immunohistochemistry.
- Staging investigations: PET-CT scan or CT scans of chest/abdomen/pelvis, bone marrow biopsy, and blood tests (CBC, LDH).
- Cardiac evaluation (ECHO or MUGA scan) and lung function tests if specific chemotherapies are planned.
- Consultation with the Hemato Oncologist to discuss the specific lymphoma subtype, treatment plan, goals, and potential side effects.
- Fertility preservation counseling for patients of childbearing age before starting chemotherapy.
- Dental check-up to prevent infections during immunosuppressive treatment.
- Arranging for support for daily activities during the treatment period.
Risks & possible complications
- Chemotherapy side effects: Nausea, vomiting, hair loss, fatigue, increased risk of infections (neutropenia), and low blood counts (anemia, thrombocytopenia).
- Specific drug toxicities: Heart damage (from drugs like doxorubicin), nerve damage (peripheral neuropathy), or allergic reactions.
- Immunotherapy-related reactions: Infusion reactions, increased risk of infections, and potential effects on other organs.
- Radiation therapy side effects (if used): Skin irritation, fatigue, and long-term risk of secondary cancers or heart/lung effects (rare).
- Risk of tumor lysis syndrome, a metabolic emergency, especially with high-grade, bulky lymphomas at treatment initiation.
- Potential for infertility or early menopause due to chemotherapy.
- Risk of lymphoma recurrence or transformation to a more aggressive type.
Recovery & hospital stay
- Treatment is typically administered in cycles (e.g., every 3 weeks), with recovery periods in between to allow the body to recuperate.
- Close monitoring for side effects and infections is crucial; patients are advised to report fever or unusual symptoms immediately.
- Regular blood tests are required to monitor blood counts and organ function throughout treatment.
- Nutritional support and managing fatigue are key components of recovery between cycles.
- After completing treatment, regular follow-up visits with the Hemato Oncologist are essential for surveillance with physical exams and periodic imaging (like PET-CT) to check for remission.
- Long-term follow-up addresses potential late effects of treatment, including cardiac monitoring and screening for secondary cancers.
- Psychosocial support and survivorship care are integral to the recovery process.
-
Typical hospital stay: Varies (Mostly outpatient for chemo; inpatient for complications or specific regimens)
-
Expected recovery time: Treatment lasts 3-6 months; full recovery may take 6-12 months
Frequently Asked Questions
If you are considering breast lymphoma in India, these questions and answers can help you make a confident, informed decision.
Top-rated hospitals in India with hemato oncology departments and experienced surgeons are ideal for this procedure. Use MediFyr to compare facilities, reviews, and doctor profiles before you decide.
Look at the doctor’s years of experience, hospital association, patient reviews, and how often they perform breast lymphoma. MediFyr helps you compare hemato oncologists and book consultations online.
The overall cost depends on hospital category, surgeon’s experience, room type, implant or device used (if any), length of stay, tests, and post-operative care. Our team can help you get cost estimates from multiple hospitals before you decide.
Procedure cost in other countries
Here is an overview of how the estimated cost, hospital stay, and recovery time for breast lymphoma compare across other countries where we have data.
| Country | Estimated cost range | Typical stay | Recovery time | View details |
|---|---|---|---|---|
| India | INR 250 Thousand – 1.2 Million | Varies (Mostly outpatient for chemo; inpatient for complications or specific regimens) | ~ Treatment lasts 3-6 months; full recovery may take 6-12 months | Know More |
| Turkey | TRY 875 Thousand – 4.2 Million | Varies (Mostly outpatient for chemo; inpatient for complications or specific regimens) | ~ Treatment lasts 3-6 months; full recovery may take 6-12 months | Know More |
Vikram Gupta, a 58-year-old accountant and...
Vikram Gupta, a 58-year-old accountant and father of two, noticed a persistent, painless lump in his left breast during a routine shower. Initially dismissing it, he grew concerned when it didn't resolve over several weeks. A visit to his GP led to an ultrasound and a core needle biopsy, which revealed abnormal lymphoid cells. He was referred to Dr. Sharma, a Hemato-Oncologist, who explained that while rare, men can develop breast lymphoma, a cancer of the lymphatic system presenting in breast tissue, not a typical breast cancer. Dr. Sharma recommended an excisional biopsy to obtain a larger tissue sample for precise subtyping, crucial for determining the exact lymphoma and subsequent treatment plan. Vikram felt anxious and isolated, struggling with the stigma of a 'female' cancer. The procedure was straightforward, performed under local anesthesia. The pathology confirmed Diffuse Large B-Cell Lymphoma (DLBCL) of the breast. This definitive diagnosis allowed Dr. Sharma to start Vikram on a targeted R-CHOP chemotherapy regimen. Post-procedure, Vikram felt a shift from uncertainty to a clear, albeit difficult, path forward. While facing chemotherapy with trepidation, he was empowered by having a specific name for his disease and a structured treatment plan. His emotional journey moved from shock and embarrassment to a focused determination, bolstered by his family's support and a defined clinical roadmap.
Hemato Oncologists for Breast Lymphoma
Explore experienced hemato oncologists who regularly perform breast lymphoma and provide pre- and post-operative care in India.
- 13 Years Experience
- Hemato Oncologist
Kamineni Hospital LB Nagar, Hyderabad
- 10 Years Experience
- Hemato Oncologist
Manipal Hospital Mukundapur, Kolkata